There have been recent updates made to the Provider Portal specific to the "Audit Guidelines" and "Maximum Allowable Cost (MAC)" sections.

This notification is to inform you of formulary changes for all Medicare Part D plans processed by EnvisionRxOptions.

On January 1, 2018 approximately 105,000 members will be transitioning to the CCC Plus program from the Aged, Blind and Disabled and for the CCC programs.

Effective January 1, 2018 EnvisionRxOptions will become the new claims processor for Affinion Group.

This notification is to inform you of point-of-sale (POS) drug utilization review (DUR) edits for opioids that will be enforced for all Commercial plans that process claims through EnvisionRxOptions (“Envision”) effective December 18, 2017.